Imiquimod is a type of topical immune therapy that comes in the form of a cream. When imiquimod is applied to skin lesions, it causes the immune system to react in such a way that may destroy cancer cells. Though most often used to treat other types of skin cancer, imiquimod can also be used to treat early-stage cutaneous T-cell lymphoma. Possible side effects for imiquimod include irritation, itching, and redness in the treated area.
Nondiscrimination Policy Update
Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.
To read our full Nondiscrimination Statement, click here.
Popular Searches